- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Obstructive Pulmonary Function in Mexico
Total 517 results
-
National Institute of Respiratory Diseases, MexicoUnknownChronic Obstructive Pulmonary DiseaseMexico
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease, COPDFrance, Poland, South Africa, Spain, United States, Canada, United Kingdom
-
National Institute of Respiratory Diseases, MexicoCompleted
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseTaiwan, Russian Federation, Mexico, Chile
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Instituto Nacional de Ciencias Medicas y Nutricion...Unknown
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia, Argentina, Japan, Russian Federation, Spain, Germany, Mexico, Romania, Korea, Republic of, Poland, Italy, France
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Poland, Romania, Russian Federation, Ukraine, Bulgaria, Estonia, Mexico, Korea, Republic of, Slovakia, Greece, China, Italy, Hungary, Czechia
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Colombia, Argentina, Germany, Spain, Turkey, Guatemala, Mexico, Australia, Denmark, South Africa, Philippines
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Canada, Germany, Argentina, Bulgaria, Poland, Turkey, Mexico, United Kingdom
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseColombia, Italy, Switzerland, Argentina, United Kingdom, Mexico, Netherlands, Malaysia, Spain
-
Instituto Nacional de Enfermedades RespiratoriasRecruitingHeart Failure | Copd | Pulmonary Rehabilitation | Nutritional SupplementationMexico
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseArgentina, Dominican Republic, Panama, Mexico, Brazil, Chile, Ecuador, Honduras
-
DeyCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
SunovionCompleted
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Hoffmann-La RocheCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada, Bulgaria, Hungary, Russian Federation, Denmark, Argentina, Mexico, Poland
-
PfizerCompletedPulmonary Disease, Chronic ObstructiveUnited States, Costa Rica, Brazil, Chile, Mexico, Argentina
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Colombia, India, Korea, Republic of, Poland, Croatia, Estonia, Hungary, United Kingdom, Israel, Latvia, Turkey, Argentina, Panama, Mexico, Russian Federation, Serbia, Slovenia
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Argentina, Australia, Canada, Mexico, New Zealand, South Africa
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Russian Federation, Ukraine, Mexico
-
Pearl Therapeutics, Inc.Completed
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States, Spain, Switzerland, France, Italy, Germany, Turkey, Hungary, Norway, Slovakia, Poland, Russian Federation, Canada, Belgium, Austria, Colombia, Denmark, Finland, Greece, Israel, Mexico, United Kingdom
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary Disease | COPDUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, United States, Netherlands, Czechia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveSouth Africa, United States, Canada, Ukraine, United Kingdom, Denmark, Czechia
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPDUnited States, Argentina, Canada, Colombia, Mexico, Peru
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, New Zealand
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, Canada, Czechia, Denmark, Hungary, Netherlands, Spain, Korea, Republic of, Argentina, Belgium, Bulgaria, Finland, India, Japan, Mexico, Norway, Sweden, Turkey, Vietnam, Portugal, Puerto Rico
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseUnited States, Argentina, Germany, Russian Federation, France, Israel, Korea, Republic of, Italy, Poland, Chile, Mexico, Peru, Canada, Hungary, Netherlands, New Zealand
-
United TherapeuticsTerminatedChronic Obstructive Pulmonary Disease | Pulmonary HypertensionUnited States, Israel, Argentina, Puerto Rico
-
AstraZenecaRecruitingCOPD (Chronic Obstructive Pulmonary Disease)United States, Korea, Republic of, Argentina, Turkey, Vietnam, Malaysia, Philippines, Thailand, Hungary, Mexico, Bulgaria, Canada, India, Poland
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada, Germany, Hungary, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, Taiwan
-
Hospital General Naval de Alta Especialidad - Escuela...Unknown
-
AstraZenecaAmgenCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Canada, Denmark, France, United Kingdom, Korea, Republic of, Germany, Israel, Spain, Netherlands
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Bulgaria, Germany, Hungary, Romania, Denmark, Greece, Mexico, Iceland
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Denmark, France, Sweden, Thailand, Vietnam, Belgium, Brazil, Peru, Philippines, Turkey, Taiwan, Argentina, Australia, Israel, Poland, Ukraine, Slovenia, Serbia, Mexico, Bulgaria, Colombia, New Zealand, Chile, Norway, Croatia
-
AstraZenecaActive, not recruitingChronic Obstructive Pulmonary Disease (COPD)United States, Denmark, Italy, United Kingdom, Canada, Germany, Turkey, Argentina, South Africa, Spain, Poland, Bulgaria, Mexico, Netherlands
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Canada, Germany, Italy, Netherlands, Spain, United Kingdom, Poland, Japan, Austria, Korea, Republic of, Russian Federation, South Africa, Czechia, Hungary, Romania, Switzerland
-
SunovionCompletedChronic Obstructive Pulmonary Disease | Emphysema | BronchitisUnited States
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseGermany, United States, Colombia, Poland, South Africa, Canada, Estonia, Hungary, India, Austria, Israel, Netherlands, United Kingdom, Argentina, France, Italy, Spain, Czech Republic, Denmark, Finland, Greece, Ireland, Mexico, Peru, Phi... and more
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Germany, Spain, Turkey, Hungary, Czech Republic, India, Slovakia
-
AstraZenecaRecruitingCOPD (Chronic Obstructive Pulmonary Disease)France, Denmark, Italy, Spain, United States, Canada, Argentina, Japan, Colombia, Germany, Peru, Brazil, China, India, Thailand, Austria, Serbia, Malaysia, Philippines, Poland, Taiwan, Greece, Norway, Sweden, Mexico, Romania, Korea, Republic... and more
-
National Institute of Respiratory Diseases, MexicoCompleted
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Colombia, India, Korea, Republic of, Poland, Romania, South Africa, Italy, Austria, Belgium, Croatia, Estonia, Hungary, Russian Federation, Taiwan, Turkey, Japan, Spain, Sweden, United Kingdom, China, Thailand, Canada, Hong Kong and more
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Japan, Russian Federation, Chile, Poland, Mexico, Estonia, Korea, Republic of, Philippines
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Canada, Germany, Spain, United States, Italy, Netherlands, South Africa, Sweden, France, Mexico, Australia